Krebs Historical Income Statement

KREBSBIO

104.14 8.79 7.78%

Historical analysis of Krebs Biochemicals income statement accounts such as Total Revenue of 274.5 M can show how well Krebs Biochemicals and performed in making a profits. Evaluating Krebs Biochemicals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Krebs Biochemicals's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Krebs Biochemicals and latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Krebs Biochemicals and is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Krebs Biochemicals and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About Krebs Income Statement Analysis

Krebs Biochemicals and Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Krebs Biochemicals shareholders. The income statement also shows Krebs investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Krebs Biochemicals Income Statement Chart

As of now, Krebs Biochemicals' Income Tax Expense is increasing as compared to previous years. The Krebs Biochemicals' current Selling And Marketing Expenses is estimated to increase to about 48.5 M, while Depreciation And Amortization is projected to decrease to under 51.5 M.

Selling General Administrative Other Operating Expenses Operating Income Cost Of Revenue Total Operating Expenses Income Tax Expense

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Krebs Biochemicals and. It is also known as Krebs Biochemicals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Krebs Biochemicals and operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Krebs Biochemicals and is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Krebs Biochemicals and income statement and represents the costs associated with goods and services Krebs Biochemicals provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Krebs Biochemicals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Krebs Biochemicals and current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Krebs Biochemicals and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	195.1M	488.0M	46.2M	43.8M
Cost Of Revenue	737M	256.8M	613.0M	342.2M

Total Operating Expenses Cost Of Revenue

Krebs Biochemicals income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling And Marketing Expenses	Net Income From Continuing Ops	Interest Income	Research Development	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.63	0.62	0.74	0.6	0.57	-0.19	0.08	0.31	0.38	0.58	-0.09	-0.23	-0.04	-0.14	0.16	0.26	-0.38	-0.13	0.29	0.11
Interest Expense	0.63		0.44	0.77	0.25	0.69	-0.39	-0.14	0.03	0.63	0.38	-0.44	-0.42	-0.4	-0.15	0.01	-0.2	0.31	0.31	-0.41	0.09
Selling General Administrative	0.62	0.44		0.54	0.63	0.38	-0.06	0.16	0.3	0.16	0.56	0.02	-0.06	0.07	-0.39	-0.1	0.38	-0.3	-0.29	0.24	-0.23
Total Revenue	0.74	0.77	0.54		0.36	0.94	-0.53	-0.35	-0.16	0.8	0.65	-0.55	-0.49	-0.51	0.17	0.34	-0.26	0.08	0.46	-0.21	0.5
Gross Profit	0.6	0.25	0.63	0.36		0.12	0.25	0.45	0.56	-0.27	0.76	0.34	0.32	0.38	-0.19	0.07	0.56	-0.29	-0.46	0.63	-0.24
Other Operating Expenses	0.57	0.69	0.38	0.94	0.12		-0.77	-0.64	-0.47	0.89	0.6	-0.79	-0.64	-0.76	0.29	0.36	-0.55	0.17	0.64	-0.37	0.64
Operating Income	-0.19	-0.39	-0.06	-0.53	0.25	-0.77		0.94	0.85	-0.72	-0.41	0.97	0.79	0.96	-0.13	-0.04	0.83	-0.11	-0.6	0.42	-0.54
Ebit	0.08	-0.14	0.16	-0.35	0.45	-0.64	0.94		0.97	-0.65	-0.24	0.95	0.7	0.96	-0.29	-0.11	0.92	-0.21	-0.71	0.5	-0.62
Ebitda	0.31	0.03	0.3	-0.16	0.56	-0.47	0.85	0.97		-0.53	-0.1	0.87	0.63	0.9	-0.28	-0.03	0.93	-0.26	-0.69	0.53	-0.56
Cost Of Revenue	0.38	0.63	0.16	0.8	-0.27	0.89	-0.72	-0.65	-0.53		0.19	-0.79	-0.72	-0.77	0.29	0.28	-0.63	0.26	0.77	-0.63	0.66
Total Operating Expenses	0.58	0.38	0.56	0.65	0.76	0.6	-0.41	-0.24	-0.1	0.19		-0.32	-0.16	-0.29	-0.01	0.13	-0.06	-0.15	0.02	0.31	0.19
Income Before Tax	-0.09	-0.44	0.02	-0.55	0.34	-0.79	0.97	0.95	0.87	-0.79	-0.32		0.77	1.0	-0.24	-0.11	0.91	-0.31	-0.76	0.59	-0.6
Total Other Income Expense Net	-0.23	-0.42	-0.06	-0.49	0.32	-0.64	0.79	0.7	0.63	-0.72	-0.16	0.77		0.77	0.07	0.14	0.66	0.12	-0.54	0.39	-0.4
Net Income	-0.04	-0.4	0.07	-0.51	0.38	-0.76	0.96	0.96	0.9	-0.77	-0.29	1.0	0.77		-0.26	-0.12	0.93	-0.33	-0.77	0.6	-0.61
Income Tax Expense	-0.14	-0.15	-0.39	0.17	-0.19	0.29	-0.13	-0.29	-0.28	0.29	-0.01	-0.24	0.07	-0.26		0.92	-0.39	0.33	0.54	-0.12	0.84
Selling And Marketing Expenses	0.16	0.01	-0.1	0.34	0.07	0.36	-0.04	-0.11	-0.03	0.28	0.13	-0.11	0.14	-0.12	0.92		-0.16	0.17	0.35	0.08	0.78
Net Income From Continuing Ops	0.26	-0.2	0.38	-0.26	0.56	-0.55	0.83	0.92	0.93	-0.63	-0.06	0.91	0.66	0.93	-0.39	-0.16		-0.44	-0.82	0.65	-0.65
Interest Income	-0.38	0.31	-0.3	0.08	-0.29	0.17	-0.11	-0.21	-0.26	0.26	-0.15	-0.31	0.12	-0.33	0.33	0.17	-0.44		0.58	-0.73	0.18
Research Development	-0.13	0.31	-0.29	0.46	-0.46	0.64	-0.6	-0.71	-0.69	0.77	0.02	-0.76	-0.54	-0.77	0.54	0.35	-0.82	0.58		-0.74	0.71
Net Interest Income	0.29	-0.41	0.24	-0.21	0.63	-0.37	0.42	0.5	0.53	-0.63	0.31	0.59	0.39	0.6	-0.12	0.08	0.65	-0.73	-0.74		-0.22
Reconciled Depreciation	0.11	0.09	-0.23	0.5	-0.24	0.64	-0.54	-0.62	-0.56	0.66	0.19	-0.6	-0.4	-0.61	0.84	0.78	-0.65	0.18	0.71	-0.22

Click cells to compare fundamentals

Krebs Biochemicals Account Relationship Matchups

Krebs Biochemicals income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	46.8M	51.2M	63.0M	65.6M	67.7M	51.5M
Interest Expense	60.0M	62.8M	54.4M	29.7M	46.9M	41.6M
Selling General Administrative	8.4M	6.7M	11.2M	8.6M	6.0M	5.7M
Total Revenue	235.8M	386.1M	529.4M	521.3M	504.2M	274.5M
Gross Profit	(93.3M)	(136.3M)	(207.6M)	264.6M	(108.7M)	(103.3M)
Other Operating Expenses	476.1M	613.1M	932.1M	744.7M	659.1M	520.4M
Operating Income	(240.3M)	(227.0M)	(402.9M)	(217.2M)	(152.0M)	(159.6M)
Ebit	(227.5M)	(220.8M)	(391.4M)	(217.2M)	(150.4M)	(157.9M)
Ebitda	(180.7M)	(169.6M)	(328.4M)	(151.6M)	(82.7M)	(86.9M)
Cost Of Revenue	329.1M	522.3M	737M	256.8M	613.0M	342.2M
Total Operating Expenses	147.0M	90.8M	195.1M	488.0M	46.2M	43.8M
Income Before Tax	(288.7M)	(283.6M)	(445.3M)	(246.9M)	(197.3M)	(207.1M)
Total Other Income Expense Net	(48.5M)	(111.2M)	(424.9M)	(27.5M)	(45.3M)	(47.6M)
Net Income	(288.7M)	(283.6M)	(445.3M)	(246.9M)	(197.3M)	(207.1M)
Income Tax Expense	12.7M	6.2M	13.9M	65.4M	67.5M	70.9M
Selling And Marketing Expenses	976K	47K	38K	40.2M	46.2M	48.5M
Net Income From Continuing Ops	(288.7M)	(283.6M)	(445.3M)	(246.9M)	(197.3M)	(207.1M)
Net Income Applicable To Common Shares	(288.7M)	(283.6M)	(445.3M)	(246.9M)	(222.2M)	(233.3M)
Interest Income	51.5M	62.8M	3.6M	29.7M	34.2M	40.7M
Research Development	9.7M	14.7M	16.4M	11.3M	12.7M	11.1M
Net Interest Income	(57.4M)	(62.8M)	(53.9M)	(29.7M)	(46.9M)	(49.2M)
Reconciled Depreciation	46.8M	51.2M	63.0M	65.6M	67.7M	59.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Krebs Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Krebs Historical Income Statement

About Krebs Income Statement Analysis

Krebs Biochemicals Income Statement Chart

Other Operating Expenses

Operating Income

Cost Of Revenue

Total Operating Expenses

Krebs Biochemicals income statement Correlations

Krebs Biochemicals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Krebs Biochemicals income statement Accounts

Also Currently Popular

Other Information on Investing in Krebs Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income	+ 1.0	Income Before Tax
Income Before Tax	+ 0.97	Operating Income
Ebitda	+ 0.97	Ebit
Net Income	+ 0.96	Operating Income
Net Income	+ 0.96	Ebit
Income Before Tax	+ 0.95	Ebit

Research Development	- 0.82	Net Income From Continuing Ops
Income Before Tax	- 0.79	Cost Of Revenue
Income Before Tax	- 0.79	Other Operating Expenses
Research Development	- 0.77	Net Income
Net Income	- 0.77	Cost Of Revenue
Operating Income	- 0.77	Other Operating Expenses